Journal profile · Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
Current Drug Discovery Technologies
ISSN 1570-1638 · eISSN 1875-6220 · Bentham
Current Drug Discovery Technologies: subscription journal; median 99 days to acceptance (71 articles, last 24 months); 72 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Current Drug Discovery Technologies is published by Bentham. By OpenAlex counts of its recent articles, its largest topics are Computational Drug Discovery Methods, Medicinal Plant Research and Synthesis and Characterization of Heterocyclic Compounds, together about 40% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
Main research topics OpenAlex counts of recent articles; shares are approximate
- Computational Drug Discovery MethodsComputer Science23.3%
- Medicinal Plant ResearchAgricultural and Biological Sciences9.3%
- Synthesis and Characterization of Heterocyclic CompoundsChemistry7.4%
- Synthesis and biological activityChemistry7.1%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics6.1%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics5%
- Nanoparticle-Based Drug DeliveryMaterials Science4.5%
- Natural Antidiabetic Agents StudiesMedicine3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Drug Discovery | Q3 | 115/161 | 28th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.9LetPub ·
- SJR 2026-06
- 0.35LetPub ·
- SNIP 2026-06
- 0.47LetPub ·
- h-index
- 56OpenAlex ·
- i10-index
- 375OpenAlex ·
- 2-year mean citedness
- 1.9OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 951 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 45 | 0 | 903 |
| 2025 | 72 | 1 | 1,309 |
| 2024 | 49 | 2 | 1,407 |
| 2023 | 63 | 3 | 1,384 |
| 2022 | 43 | 0 | 1,251 |
| 2021 | 16 | 3 | 1,187 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
99 daysMedian, submission to acceptance · P25–P75 68 days – 124 days
- Acceptance to online
- median 226 days (71 articles)
- Submission to online
- median 342 days
- Sample
- 71 articles with submission and acceptance dates (155 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Bentham
- ISSN
- 1570-1638
- Electronic ISSN
- 1875-6220
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Current Drug Discovery Technologies
How long does peer review take at Current Drug Discovery Technologies?
Based on the dates recorded on 71 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 99 days (interquartile range 68–124 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Current Drug Discovery Technologies?
According to LetPub and DOAJ records, Current Drug Discovery Technologies is indexed in Scopus.
Is Current Drug Discovery Technologies open access, and what is the APC?
Current Drug Discovery Technologies is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .